Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Public Health. 2005 May;95(5):790-9.

Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951-1953.

Author information

  • Department of Infectious Diseases, University of Pittsburgh Graduate School of Public Health, School of Public Health, PA 15261, USA. rinaldo@pitt.edu

Abstract

Poliomyelitis has gone from being one of the worst scourges of the 20th century to nearing eradication in the 21st. This success is well known to be attributable to the Salk inactivated and Sabin attenuated poliovirus vaccines.However, before introduction of these vaccines, William McDowall Hammon of the University of Pittsburgh Graduate School of Public Health led the first major breakthrough in prevention of the disease by using passive immunization in one of the earliest double-blind, placebo-controlled clinical trials. This study provided the first evidence that antibodies to poliovirus could prevent the disease in humans.

PMID:
15855454
[PubMed - indexed for MEDLINE]
PMCID:
PMC1449257
Free PMC Article

Images from this publication.See all images (4)Free text

FIGURE 1—
FIGURE 2—
FIGURE 3—
FIGURE 4—
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk